Abstract
Background
Gastroesophageal reflux disease (GERD) is associated with epithelial injury and inflammation of the upper gastrointestinal tract. Long-term pharmacological therapies may present limitations, encouraging interest in complementary approaches.
Aim
This study evaluated the in vitro wound healing and anti-inflammatory activity of the multicomponent gel food supplement Reflus Gel® (RG), formulated for gastric acidity management.
Methods
Wound healing was assessed using a scratch assay on fully confluent Caco-2 cells, while anti-inflammatory activity was evaluated by measuring interleukin (IL)-1β, IL-6, and tumour necrosis factor (TNF)-α release in lipopolysaccharide-stimulated THP-1-derived macrophages by enzyme-linked immunosorbent assay.
Results
RG enhanced wound closure at 24 and 48 h compared with untreated control (p < 0.0001) and reduced IL-1β (p < 0.01), IL-6 and TNF-α (p < 0.0001) secretion in stimulated macrophages.
Conclusions
These findings indicate that RG promotes cell migration and modulates inflammatory responses in vitro, suggesting a potential role as a complementary strategy in GERD management.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
